Neurology ReviewsDetailed glioblastoma map could lead to better treatment approachesFebruary 22, 2021Neuro-oncology
Neurology ReviewsGenomic analysis reveals insights into pathogenesis of neuroblastomaNovember 9, 2020Neuro-oncology
Neurology ReviewsEvaluating the impact of new pediatric brain tumor classificationsOctober 26, 2020Neuro-oncologyPediatrics
Subgroups predict adjuvant chemoradiotherapy benefits in low-grade gliomaAugust 21, 2020Neuro-oncology
Clinical Neurology NewsGlioma trials should track living well, not just longerFebruary 9, 2020Neuro-oncology
Clinical Neurology NewsQoL good for MGMT-methylated glioblastoma patients with lomustine-temozolideJanuary 2, 2020Neuro-oncology
Clinical Neurology NewsResearchers seek a way to predict cognitive deficits in children treated for ALLNovember 15, 2019PediatricsNeuro-oncology
Clinical Neurology NewsTandem transplants provide EFS edge in pediatric neuroblastomaAugust 29, 2019PediatricsNeuro-oncology
Neurology ReviewsTreatment for pediatric low-grade glioma is associated with poor cognitive and socioeconomic outcomesJune 29, 2019PediatricsNeuro-oncology
Clinical Neurology NewsLiquid biopsy falls short for isolated brain lesions in lung cancerApril 16, 2019Neuro-oncology
Neurology ReviewsVirus-Specific T-Cell Infusions May Resolve Progressive Multifocal LeukoencephalopathyDecember 11, 2018Multiple SclerosisNeuro-oncology
Clinical Neurology NewsProposed neuroblastoma classification scheme hinges on telomere maintenance mechanismsDecember 6, 2018Neuro-oncology
Clinical Neurology NewsCNS lymphoma guidelines stress patient fitness, not age, in choosing treatmentNovember 30, 2018Neuro-oncology
